What is the appropriate treatment for nasal congestion in children, including age-specific recommendations?

Treatment of Pediatric Nasal Congestion

For children with nasal congestion, treatment selection depends critically on age and underlying cause: use saline nasal irrigation for all ages ≥3 months, honey for children ≥1 year with common cold, and reserve intranasal corticosteroids for allergic rhinitis in children ≥3-4 years.

Age-Specific Treatment Approach

Infants and Young Children (<4 years)

For the common cold in this age group, safe and effective options are extremely limited:

• Saline nasal irrigation is the primary treatment for infants ≥3 months, showing benefit for rhinological symptoms and reducing antibiotic use 1, 2
• Honey (1 teaspoon as needed) for children ≥1 year effectively treats cough and congestion 1
• Topical ointments containing camphor, menthol, and eucalyptus oils can be applied to chest/neck 1
• Intranasal ipratropium is safe and effective for rhinorrhea 1
• Over-the-counter cold medications should NOT be used in children <4 years due to safety concerns 1

Children 4-11 Years

For Common Cold:

• Saline nasal irrigation remains first-line for mechanical decongestion 2
• Pseudoephedrine 30 mg (ages 6-11 years) provides temporary relief, though somnolence occurs more frequently than placebo (71.9% vs 63.9%) 3
• Honey continues to be effective and safe 1
• Hypertonic nasal solutions (such as those containing Pirometaxine) show efficacy without adverse events for short-term use 4

For Allergic Rhinitis:

• Intranasal corticosteroids are first-line for persistent symptoms:

  • Mometasone furoate approved for ≥3 years 5
  • Fluticasone propionate approved for ≥4 years 5
  • Other intranasal corticosteroids (beclomethasone, triamcinolone, budesonide, flunisolide) approved for ≥6 years 5

• Second-generation oral antihistamines for mild, intermittent symptoms:

  • Cetirizine and loratadine approved for children <5 years 5
  • Fexofenadine available for older children 5
  • Preferred over first-generation antihistamines due to less sedation and cognitive impairment 5

• Intranasal azelastine (antihistamine spray) is an alternative with anti-inflammatory properties 5

Adolescents (≥12 years)

Follow adult allergic rhinitis guidelines:

• Intranasal corticosteroids alone are recommended as monotherapy rather than combination with oral antihistamines for initial treatment 6
• Combination intranasal corticosteroid + intranasal antihistamine may be considered for moderate-to-severe symptoms, showing clinically meaningful improvement in total nasal symptom scores (reductions of -5.31 to -5.7 vs -3.84 to -5.1 for corticosteroid alone) 6
• Leukotriene receptor antagonists (montelukast) are less effective than intranasal corticosteroids but acceptable if patient refuses nasal spray 6

Critical Safety Considerations

Avoid sympathomimetic decongestants in children <12 years when possible due to potential systemic adverse effects, though pseudoephedrine has demonstrated safety in ages 6-11 years with appropriate dosing 5, 3

For short-term corticosteroid use (1-2 months), first-generation intranasal corticosteroids are acceptable; for longer-term treatment, prefer mometasone or fluticasone due to lower bioavailability and better safety profiles 5

Acetylcysteine is established as safe and effective in children but is underutilized 1

Common Pitfalls

• Do not prescribe antibiotics for viral upper respiratory infections or chronic rhinosinusitis without clear bacterial indication 2, 7
• Do not use combination oral antihistamine-decongestant products in young children due to safety concerns 1
• Do not assume all nasal congestion is infectious; consider allergic rhinitis, which affects up to 40% of children and typically presents by age 6 years 5, 8
• Educate parents that common colds are self-limited, typically resolving within 7 days, to manage expectations and prevent unnecessary medication use 1, 9